JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van de Velde, M.
Right arrow Articles by Verhaeghe, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van de Velde, M.
Right arrow Articles by Verhaeghe, J.
Related Collections
Right arrow Cardiovascular
Right arrow Obstetrics
Right arrow Regional Anesthesia
Right arrow Pharmacology

Anesth Analg 2004;98:1153-1159
© 2004 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000101980.34587.66


OBSTETRIC ANESTHESIA

Intrathecal Sufentanil and Fetal Heart Rate Abnormalities: A Double-Blind, Double Placebo-Controlled Trial Comparing Two Forms of Combined Spinal Epidural Analgesia with Epidural Analgesia in Labor

M. Van de Velde, MD, PhD*, A. Teunkens, MD*, M. Hanssens, MD, PhD, FRCOG{dagger}, E. Vandermeersch, MD, PhD*, and J. Verhaeghe, MD, PhD{dagger}

Departments of *Anesthesiology and {dagger}Obstetrics and Gynecology, University Hospitals Gasthuisberg, Katholieke Universiteit Leuven, Herestraat, Belgium

Address correspondence and reprint requests to Marc Van de Velde, MD, PhD, Director Obstetric Anesthesia and Extra Muros Anesthesia, Department of Anesthesiology, University Hospitals Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. Address e-mail to marc.vandevelde{at}uz.kuleuven.ac.be

Combined spinal epidural analgesia (CSE) for labor pain relief has become increasingly popular. However, the effect of intrathecal sufentanil on the incidence of uterine hyperactivity and fetal heart rate (FHR) abnormalities remains controversial. We hypothesized that the use of intrathecal sufentanil in a dose of 7.5 µg is more likely to induce a nonreassuring FHR tracing than a small dose of spinal sufentanil combined with bupivacaine or epidural analgesia. Three-hundred parturients were randomized into three groups. In the first group, epidural analgesia was initiated with 12.5 mg of bupivacaine, 12.5 µg of epinephrine, and 7.5 µg of sufentanil in a volume of 10 mL (EPD group). In Group 2, initial intrathecal analgesia consisted of 2.5 mg of bupivacaine, 2.5 µg of epinephrine, and 1.5 µg of sufentanil (BSE group); in Group 3, spinal analgesia consisted of 7.5 µg of sufentanil (SUF group). Analgesia was maintained in all groups with patient-controlled epidural analgesia using bupivacaine 0.125%, 1.25 µg/mL of epinephrine, and 0.75 µg/mL of sufentanil (bolus, 4 mL; lockout, 15 min). Cardiotocography was monitored continuously 15 min before analgesia and for 60 min after the start of analgesia. The quality of analgesia, labor, and neonatal outcome and side effects were recorded. Twenty-four percent of patients in the SUF group developed FHR abnormalities (bradycardia or late decelerations) during the first hour after initiation of analgesia compared with 12% in the BSE group and 11% in the EPD group. Uterine hyperactivity occurred in 12% of parturients in the SUF group but in only 2% in the other groups. Onset of analgesia was more rapid in both CSE groups as compared with the EPD group. However, 29% of patients in the BSE group developed severe hypotension, requiring IV ephedrine (29% in the BSE group versus 7% and 12% in the EPD and SUF groups, respectively). All these differences reached statistical significance. The present data corroborate previous recommendations of caution when performing CSE using a large dose (7.5 µg or more) of spinal sufentanil because of the risk of uterine hyperactivity and FHR abnormalities.

IMPLICATIONS: Combined spinal epidural analgesia (CSE) produces pain relief during labor. Fetal heart rate changes after CSE using intrathecal sufentanil have been reported. We performed a randomized, blinded trial confirming that fetal heart rate changes are more frequent after CSE using 7.5 µg of intrathecal sufentanil as compared with other forms of neuraxial labor analgesia.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
S. R. Goodman, R. M. Smiley, M. A. Negron, P. A. Freedman, and R. Landau
A Randomized Trial of Breakthrough Pain During Combined Spinal-Epidural Versus Epidural Labor Analgesia in Parous Women
Anesth. Analg., January 1, 2009; 108(1): 246 - 251.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. Cappiello, N. O'Rourke, S. Segal, and L. C. Tsen
A Randomized Trial of Dural Puncture Epidural Technique Compared with the Standard Epidural Technique for Labor Analgesia
Anesth. Analg., November 1, 2008; 107(5): 1646 - 1651.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. S. Lee and M. V. de Velde
Does Intrathecal Sufentanil Really Cause More Episodes of Fetal Bradycardia? * Response
Anesth. Analg., October 1, 2004; 99(4): 1267 - 1267.
[Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2004 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2004 by the International Anesthesia Research Society.